Phibro Animal Health Stock EBITDA

PAHC Stock

USD 16.77 0.32 1.95%

Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.

		Last Reported	Projected for Next Year
	EBITDA	124.8 M	131 M

The current year's EBITDA is expected to grow to about 131 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Phibro Animal Health Company EBITDA Analysis

Phibro Animal's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Phibro Animal EBITDA

108.49 M

Most of Phibro Animal's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Phibro EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Phibro Animal is extremely important. It helps to project a fair market value of Phibro Stock properly, considering its historical fundamentals such as EBITDA. Since Phibro Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phibro Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phibro Animal's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	0.72	0.9	0.68	0.66	0.75	0.74	0.8	0.84	0.63	-0.22	0.79	0.96	0.94	0.33	0.68	0.21	-0.66	0.67	0.91	0.88	0.87	0.87	-0.65
Total Stockholder Equity	0.91		0.54	0.98	0.53	0.43	0.78	0.54	0.76	0.86	0.64	-0.54	0.75	0.92	0.96	0.3	0.73	0.31	-0.76	0.57	0.89	0.92	0.81	0.82	-0.52
Net Debt	0.72	0.54		0.55	0.77	0.67	0.77	0.97	0.89	0.6	0.67	0.14	0.9	0.72	0.59	0.38	0.59	0.01	-0.38	0.85	0.72	0.67	0.84	0.82	-0.19
Retained Earnings	0.9	0.98	0.55		0.51	0.49	0.75	0.54	0.75	0.91	0.61	-0.51	0.76	0.93	0.95	0.31	0.76	0.24	-0.71	0.63	0.9	0.91	0.83	0.84	-0.52
Accounts Payable	0.68	0.53	0.77	0.51		0.48	0.81	0.88	0.86	0.48	0.62	0.18	0.72	0.62	0.61	0.06	0.4	0.19	-0.48	0.59	0.62	0.59	0.69	0.71	-0.12
Long Term Debt	0.66	0.43	0.67	0.49	0.48		0.33	0.61	0.48	0.67	0.15	0.15	0.53	0.67	0.5	0.27	0.4	-0.41	0.08	0.76	0.64	0.38	0.73	0.7	-0.55
Net Receivables	0.75	0.78	0.77	0.75	0.81	0.33		0.8	0.96	0.63	0.74	-0.24	0.9	0.72	0.8	0.31	0.64	0.26	-0.66	0.62	0.8	0.84	0.82	0.85	-0.12
Total Liab	0.74	0.54	0.97	0.54	0.88	0.61	0.8		0.91	0.55	0.72	0.24	0.88	0.71	0.61	0.32	0.57	0.1	-0.46	0.76	0.7	0.69	0.79	0.78	-0.17
Total Current Assets	0.8	0.76	0.89	0.75	0.86	0.48	0.96	0.91		0.69	0.78	-0.08	0.96	0.79	0.79	0.33	0.71	0.23	-0.64	0.73	0.82	0.84	0.86	0.87	-0.14
Short Term Debt	0.84	0.86	0.6	0.91	0.48	0.67	0.63	0.55	0.69		0.45	-0.41	0.72	0.89	0.84	0.3	0.78	0.04	-0.49	0.75	0.87	0.77	0.85	0.84	-0.5
Intangible Assets	0.63	0.64	0.67	0.61	0.62	0.15	0.74	0.72	0.78	0.45		-0.14	0.8	0.7	0.56	0.2	0.65	0.38	-0.8	0.5	0.57	0.8	0.51	0.49	0.04
Common Stock	-0.22	-0.54	0.14	-0.51	0.18	0.15	-0.24	0.24	-0.08	-0.41	-0.14		-0.16	-0.31	-0.35	-0.11	-0.25	-0.26	0.39	-0.16	-0.31	-0.36	-0.25	-0.26	0.22
Property Plant Equipment	0.79	0.75	0.9	0.76	0.72	0.53	0.9	0.88	0.96	0.72	0.8	-0.16		0.83	0.75	0.49	0.77	0.17	-0.6	0.83	0.83	0.85	0.87	0.86	-0.16
Good Will	0.96	0.92	0.72	0.93	0.62	0.67	0.72	0.71	0.79	0.89	0.7	-0.31	0.83		0.89	0.33	0.76	0.2	-0.66	0.76	0.9	0.88	0.86	0.84	-0.54
Net Tangible Assets	0.94	0.96	0.59	0.95	0.61	0.5	0.8	0.61	0.79	0.84	0.56	-0.35	0.75	0.89		0.31	0.71	0.27	-0.69	0.54	0.91	0.89	0.84	0.86	-0.57
Current Deferred Revenue	0.33	0.3	0.38	0.31	0.06	0.27	0.31	0.32	0.33	0.3	0.2	-0.11	0.49	0.33	0.31		0.29	0.05	-0.2	0.4	0.41	0.35	0.4	0.4	-0.23
Short Term Investments	0.68	0.73	0.59	0.76	0.4	0.4	0.64	0.57	0.71	0.78	0.65	-0.25	0.77	0.76	0.71	0.29		0.15	-0.57	0.58	0.78	0.75	0.65	0.64	-0.22
Deferred Long Term Liab	0.21	0.31	0.01	0.24	0.19	-0.41	0.26	0.1	0.23	0.04	0.38	-0.26	0.17	0.2	0.27	0.05	0.15		-0.74	-0.04	0.13	0.24	0.06	0.07	-0.01
Short Long Term Debt	-0.66	-0.76	-0.38	-0.71	-0.48	0.08	-0.66	-0.46	-0.64	-0.49	-0.8	0.39	-0.6	-0.66	-0.69	-0.2	-0.57	-0.74		-0.29	-0.56	-0.79	-0.45	-0.46	0.18
Long Term Debt Total	0.67	0.57	0.85	0.63	0.59	0.76	0.62	0.76	0.73	0.75	0.5	-0.16	0.83	0.76	0.54	0.4	0.58	-0.04	-0.29		0.73	0.59	0.88	0.83	-0.28
Capital Surpluse	0.91	0.89	0.72	0.9	0.62	0.64	0.8	0.7	0.82	0.87	0.57	-0.31	0.83	0.9	0.91	0.41	0.78	0.13	-0.56	0.73		0.85	0.92	0.92	-0.6
Long Term Investments	0.88	0.92	0.67	0.91	0.59	0.38	0.84	0.69	0.84	0.77	0.8	-0.36	0.85	0.88	0.89	0.35	0.75	0.24	-0.79	0.59	0.85		0.78	0.78	-0.37
Net Invested Capital	0.87	0.81	0.84	0.83	0.69	0.73	0.82	0.79	0.86	0.85	0.51	-0.25	0.87	0.86	0.84	0.4	0.65	0.06	-0.45	0.88	0.92	0.78		1.0	-0.48
Net Working Capital	0.87	0.82	0.82	0.84	0.71	0.7	0.85	0.78	0.87	0.84	0.49	-0.26	0.86	0.84	0.86	0.4	0.64	0.07	-0.46	0.83	0.92	0.78	1.0		-0.48
Capital Stock	-0.65	-0.52	-0.19	-0.52	-0.12	-0.55	-0.12	-0.17	-0.14	-0.5	0.04	0.22	-0.16	-0.54	-0.57	-0.23	-0.22	-0.01	0.18	-0.28	-0.6	-0.37	-0.48	-0.48

Click cells to compare fundamentals

Phibro EBITDA Historical Pattern

Today, most investors in Phibro Animal Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Phibro Animal's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Phibro Animal ebitda as a starting point in their analysis.

Phibro Animal EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Phibro Animal

Ebitda Over Time

Phibro Ebitda

Ebitda

131 Million

At present, Phibro Animal's EBITDA is projected to increase significantly based on the last few years of reporting.

According to the company disclosure, Phibro Animal Health reported earnings before interest,tax, depreciation and amortization of 108.49 M. This is 87.64% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 97.22% higher than that of the company.

Phibro EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.

Phibro Animal is currently under evaluation in ebitda category among related companies.

Phibro Animal Institutional Holders

Institutional Holdings refers to the ownership stake in Phibro Animal that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Phibro Animal's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Phibro Animal's value.

		Shares
Smith Graham & Co Inv Adv, L.p.**	2023-12-31	447.9 K
Goldman Sachs Group Inc	2023-12-31	390.6 K
Morgan Stanley - Brokerage Accounts	2023-12-31	388.2 K
Amvescap Plc.	2023-12-31	314.7 K
Brandywine Global Investment Mgmt Llc	2023-12-31	287.7 K
Nuveen Asset Management, Llc	2023-12-31	270.6 K
Charles Schwab Investment Management Inc	2023-12-31	244.7 K
Northern Trust Corp	2023-12-31	243.7 K
Bank Of New York Mellon Corp	2023-12-31	243.4 K
Blackrock Inc	2023-12-31	3.7 M
Brandes Investment Partners & Co	2023-12-31	2.1 M

Phibro Fundamentals

	Return On Equity	0.0549
	Return On Asset	0.0372
	Profit Margin	0.02 %
	Operating Margin	0.06 %
	Current Valuation	1.09 B
	Shares Outstanding	20.34 M
	Shares Owned By Insiders	0.62 %
	Shares Owned By Institutions	99.38 %
	Number Of Shares Shorted	626.54 K
	Price To Earning	11.39 X
	Price To Book	1.96 X
	Price To Sales	0.54 X
	Revenue	977.89 M
	Gross Profit	298.24 M
	EBITDA	108.49 M
	Net Income	32.61 M
	Cash And Equivalents	98.67 M
	Cash Per Share	2.44 X
	Total Debt	509.97 M
	Debt To Equity	1.79 %
	Current Ratio	2.97 X
	Book Value Per Share	6.69 X
	Cash Flow From Operations	13.31 M
	Short Ratio	4.82 X
	Earnings Per Share	0.37 X
	Price To Earnings To Growth	1.66 X
	Target Price	10.75
	Number Of Employees	1.92 K
	Beta	0.74
	Market Capitalization	679.25 M
	Total Asset	971.4 M
	Retained Earnings	260.91 M
	Working Capital	409.72 M
	Current Asset	342.83 M
	Current Liabilities	108.78 M
	Annual Yield	0.03 %
	Five Year Return	1.85 %
	Net Asset	971.4 M
	Last Dividend Paid	0.48

About Phibro Animal Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phibro Animal Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis.

Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Fundamental Analysis View fundamental data based on most recent published financial statements

Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.83)

Dividend Share

0.48

Earnings Share

0.37

Revenue Per Share

24.245

Quarterly Revenue Growth

0.022

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Animal Health Stock EBITDA

Phibro Animal Health Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Phibro Animal EBITDA

Phibro EBITDA Driver Correlations

Phibro EBITDA Historical Pattern

Phibro Ebitda

Ebitda

131 Million

Phibro EBITDA Peer Comparison

Phibro Animal Institutional Holders

Phibro Fundamentals

About Phibro Animal Fundamental Analysis

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Phibro Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY